PAS
HAE icon

Point72 Asia (Singapore)’s Haemonetics HAE Stock Holding History

Point72 Asia (Singapore)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$427K Buy
+8,764
New +$542K 0.07% 189
2024
Q3 		– Sell
-1,694
Closed -$140K – 1125
2024
Q2 		$140K Buy
+1,694
New +$149K 0.03% 394

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.82B AUM 7.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asia (Singapore)'s HAE Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Haemonetics (HAE) in Q3 2025: 8,764 shares worth $427K. The stake represents 0.07% of the portfolio and ranks #189 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in HAE as recently as Q2 2024.

Point72 Asia (Singapore) first reported a position in HAE in Q2 2024 and has held it in 2 quarters since. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Point72 Asia (Singapore) held 8,764 shares of Haemonetics worth $427K as of Q3 2025.
  • Haemonetics was a new Point72 Asia (Singapore) position in Q3 2025.
  • Haemonetics made up 0.07% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #189 holding.
  • Point72 Asia (Singapore) first reported a position in Haemonetics in Q2 2024 and has held it in 2 quarters since.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.